TC BioPharm (Holdings) plc Annual Net Cash Provided by (Used in) Financing Activities in GBP from 2022 to 2023

Taxonomy & unit
us-gaap: GBP
Description
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
Summary
TC BioPharm (Holdings) plc quarterly/annual Net Cash Provided by (Used in) Financing Activities history and growth rate from 2022 to 2023.
  • TC BioPharm (Holdings) plc Net Cash Provided by (Used in) Financing Activities for the quarter ending March 31, 2024 was £933K, a 76.4% decline year-over-year.
  • TC BioPharm (Holdings) plc annual Net Cash Provided by (Used in) Financing Activities for 2023 was £8.52M, a 54.3% decline from 2022.
Net Cash Provided by (Used in) Financing Activities, Annual (GBP)
Net Cash Provided by (Used in) Financing Activities, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 8.52M -10.1M -54.3% Jan 1, 2023 Dec 31, 2023 10-K 2024-04-01
2022 18.7M Jan 1, 2022 Dec 31, 2022 10-K 2024-04-01
* An asterisk sign (*) next to the value indicates that the value is likely invalid.